Drug details
Herceptin Hylecta (trastuzumab and hyaluronidase-oysk injection, for subcutaneous use)
type of Antineoplastics, Anti-HER2
Herceptin Hylecta (trastuzumab and hyaluronidase-oysk) is a combination of a HER2/neu receptor antagonist, and an endoglycosidase, indicated in adults for the treatment of HER2-overexpressing breast cancer.
This drug may have the following side effects:
- hives,
- difficulty breathing,
- swelling of your face, lips, tongue, or throat,
- nausea,
- rash,
- diarrhea,
- fever,
- lightheadedness,
- shortness of breath,
- chills,
- rapid breathing,
- tiredness,
- chest pain,
- dizziness,
- fluttering in your chest,
- wheezing,
- trouble swallowing,
- sore throat,
- rapid weight gain,
- lightheadedness
- fast or pounding heartbeats,
- new or worsening cough,
- pain when you breathe,
- skin sores,
- red or swollen gums,
- gasping for breath,
- cold hands and feet, and
- blisters or ulcers in your mouth,
- swelling in your face or lower legs,
- cough foamy mucus,
The following drugs are related to Herceptin Hylecta, either as a replacement or used together:
- Verzenio (abemaciclib tablets)
- Kadcyla (ado-trastuzumab emtansine injection for iv use)
- Aredia (pamidronate disodium)
- Aromasin (exemestane)
- Ayvakit (avapritinib tablets)
- Xeloda (capecitabine)
- Halaven Injection (eribulin mesylate)
- Evista (raloxifene)
- Fareston (toremifene)
- Faslodex (fulvestrant)
- Femara (letrozole)
- Gemzar (gemcitabine hcl)
- Herceptin (trastuzumab)
- Ibrance (palbociclib capsules for oral administration)
- Ixempra (ixabepilone)
- Kisqali (ribociclib tablets)
- Kisqali FeMara Co-Pack (ribociclib and letrozole tablets)
- Lynparza (olaparib capsules for oral administration)
- Nerlynx (neratinib tablets)
- Phesgo (pertuzumab, trastuzumab, and hyaluronidase-zzxf injection)
- Trodelvy (sacituzumab govitecan-hziy for injection, for iv use)
- Thiotepa (thiotepa injection)